Loading…
MicroPort Endovascular MedTech Group announced it will spend USD 65 million to acquire the remaining 72.7% stake in Optimum Medical Device, an asset-holding firm whose core asset is UK-based Lombard Medical, a developer of aortic stents.
心脉医疗's subsidiary MICROPORT ENDOVASTEC B.V. will acquire the remaining 72.37% stake in Optimum Medical Device Inc. (OMD) for $65 million, making OMD a wholly owned subsidiary. OMD holds Lombard Medical, which makes aortic stent graft products.